Stay updated on T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Old and new screenshots show the same list of study record versions, with no additions or deletions to the study content; differences are only UI chrome in the Record History view. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T01:32:47.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    Updated operating status notice and version to v3.2.0; removes previous v3.1.0 reference and directs users to current status sources.
    Difference
    10%
    Check dated 2025-10-05T10:28:41.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0.
    Difference
    0.2%
    Check dated 2025-09-28T03:21:39.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    New version v3.0.2 is released with a Study Status Contacts/Locations entry (dated 2025-09-08) and a page date of 2025-09-09, replacing the old 2025-08-11 entry and v3.0.1, while removing the Back to Top link.
    Difference
    2%
    Check dated 2025-09-13T17:40:19.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.6%
    Check dated 2025-09-06T15:25:39.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while several location-related terms have been removed.
    Difference
    44%
    Check dated 2025-08-30T12:12:14.000Z thumbnail image

Stay in the know with updates to T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.